SAMRAT PHARMACHEM
Back to Cashflow Statement
|
SAMRAT PHARMACHEM Last 5 Year Cash Flow from Operating Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹-10 Cr | ₹9.41 Cr | ₹-9.44 Cr | ₹17 Cr | ₹4.80 Cr |
What is the latest Cash Flow from Operating Activities ratio of SAMRAT PHARMACHEM ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹-10 Cr |
| Mar2024 | ₹9.41 Cr |
| Mar2023 | ₹-9.44 Cr |
| Mar2022 | ₹17 Cr |
| Mar2021 | ₹4.80 Cr |
How is Cash Flow from Operating Activities of SAMRAT PHARMACHEM Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-10 Cr | Negative | |
| Mar2024 | ₹9.41 Cr | Positive | |
| Mar2023 | ₹-9.44 Cr | Negative | |
| Mar2022 | ₹17 Cr | 264.19 | |
| Mar2021 | ₹4.80 Cr | - | |
Compare Cash Flow from Operating Activities of peers of SAMRAT PHARMACHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SAMRAT PHARMACHEM | ₹74.0 Cr | 0.3% | 10.4% | -34% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,431.0 Cr | -0.4% | -0.1% | -2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,772.0 Cr | 0.9% | -3% | 0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹137,884.0 Cr | 2% | 1.7% | 25.2% | Stock Analytics | |
| CIPLA | ₹107,503.0 Cr | -0.9% | -7.2% | -9.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,798.0 Cr | -0.6% | 6.8% | 2.7% | Stock Analytics | |
SAMRAT PHARMACHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAMRAT PHARMACHEM | 0.3% |
10.4% |
-34% |
| SENSEX | -1.1% |
-1.2% |
5.9% |
You may also like the below Video Courses